• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒肺炎(COVID-19)的特征、诊断和治疗的免疫学方面。

Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19).

机构信息

Division of Infectious Diseases and Tropical Medicine, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.

Division of Rheumatology, Immunology, and Allergy, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.

出版信息

J Biomed Sci. 2020 Jun 4;27(1):72. doi: 10.1186/s12929-020-00663-w.

DOI:10.1186/s12929-020-00663-w
PMID:32498686
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7270518/
Abstract

On March 11, 2020, the World Health Organization declared the worldwide spread of the infectious disease COVID-19, caused by a new strain of coronavirus, SARS-CoV-2, as a pandemic. Like in all other infectious diseases, the host immune system plays a key role in our defense against SARS-CoV-2 infection. However, viruses are able to evade the immune attack and proliferate and, in susceptible individuals, cause severe inflammatory response known as cytokine storm, particularly in the lungs. The advancement in our understanding of the mechanisms underlying the host immune responses promises to facilitate the development of approaches for prevention or treatment of diseases. Components of immune system, such as antibodies, can also be used to develop sensitive and specific diagnostic methods as well as novel therapeutic agents. In this review, we summarize our knowledge about how the host mounts immune responses to infection by SARS-CoV-2. We also describe the diagnostic methods being used for COVID-19 identification and summarize the current status of various therapeutic strategies, including vaccination, being considered for treatment of the disease.

摘要

2020 年 3 月 11 日,世界卫生组织宣布由新型冠状病毒 SARS-CoV-2 引起的传染病 COVID-19 在全球范围内传播为大流行。与所有其他传染病一样,宿主免疫系统在我们抵御 SARS-CoV-2 感染的过程中起着关键作用。然而,病毒能够逃避免疫攻击并增殖,在易感个体中引起严重的炎症反应,称为细胞因子风暴,特别是在肺部。我们对宿主免疫反应机制的理解的进步有望促进预防或治疗疾病方法的发展。免疫系统的成分,如抗体,也可用于开发敏感和特异的诊断方法以及新型治疗剂。在这篇综述中,我们总结了宿主对 SARS-CoV-2 感染产生免疫反应的机制。我们还描述了用于 COVID-19 鉴定的诊断方法,并总结了各种治疗策略的现状,包括正在考虑用于治疗该疾病的疫苗接种。

相似文献

1
Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19).新型冠状病毒肺炎(COVID-19)的特征、诊断和治疗的免疫学方面。
J Biomed Sci. 2020 Jun 4;27(1):72. doi: 10.1186/s12929-020-00663-w.
2
The COVID-19 pandemic.新型冠状病毒肺炎(COVID-19)疫情。
Crit Rev Clin Lab Sci. 2020 Sep;57(6):365-388. doi: 10.1080/10408363.2020.1783198. Epub 2020 Jul 9.
3
COVID-19: Coronavirus replication, pathogenesis, and therapeutic strategies.新型冠状病毒肺炎:冠状病毒复制、发病机制及治疗策略
Cleve Clin J Med. 2020 Jun;87(6):321-327. doi: 10.3949/ccjm.87a.20047. Epub 2020 May 4.
4
Immune Response Resetting as a Novel Strategy to Overcome SARS-CoV-2-Induced Cytokine Storm.免疫反应重置作为克服 SARS-CoV-2 诱导的细胞因子风暴的一种新策略。
J Immunol. 2020 Nov 15;205(10):2566-2575. doi: 10.4049/jimmunol.2000892. Epub 2020 Sep 21.
5
Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals.新型冠状病毒感染恢复期个体中 SARS-CoV-2 特异性体液和细胞免疫的检测。
Immunity. 2020 Jun 16;52(6):971-977.e3. doi: 10.1016/j.immuni.2020.04.023. Epub 2020 May 3.
6
Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents.利用免疫系统克服 COVID-19 中的细胞因子风暴并降低病毒载量:疾病各阶段和治疗药物综述。
Virol J. 2020 Oct 15;17(1):154. doi: 10.1186/s12985-020-01415-w.
7
[COVID-19- what have we learned and where are we heading?].[新冠疫情——我们学到了什么,又将走向何方?]
Laeknabladid. 2020 Oct;106(10):449. doi: 10.17992/lbl.2020.10.598.
8
COVID-19: a conundrum to decipher.COVID-19:一个待破译的谜。
Eur Rev Med Pharmacol Sci. 2020 May;24(10):5830-5841. doi: 10.26355/eurrev_202005_21378.
9
Remodeling of the Immune Response With Aging: Immunosenescence and Its Potential Impact on COVID-19 Immune Response.免疫反应随衰老而重塑:免疫衰老及其对 COVID-19 免疫反应的潜在影响。
Front Immunol. 2020 Aug 7;11:1748. doi: 10.3389/fimmu.2020.01748. eCollection 2020.
10
Early Insights into Immune Responses during COVID-19.对 COVID-19 期间免疫反应的早期洞察。
J Immunol. 2020 Aug 1;205(3):555-564. doi: 10.4049/jimmunol.2000526. Epub 2020 Jun 8.

引用本文的文献

1
Short-term effects of COVID-19 vaccines on cardiac biomarkers: A comparative study between Pfizer/BioNTech and Sinopharm.新冠病毒疫苗对心脏生物标志物的短期影响:辉瑞/生物新技术公司与国药集团的对比研究
Qatar Med J. 2024 Dec 30;2024(4):73. doi: 10.5339/qmj.2024.73. eCollection 2024.
2
Circulating myeloid-derived suppressor cells may be a useful biomarker in the follow-up of unvaccinated COVID-19 patients after hospitalization.循环髓系来源的抑制性细胞可能是 COVID-19 未接种疫苗患者出院后随访的一个有用的生物标志物。
Front Immunol. 2023 Nov 14;14:1266659. doi: 10.3389/fimmu.2023.1266659. eCollection 2023.
3
Laboratory Features of Hospitalised Patients with COVID-19 in Jersey, UK.

本文引用的文献

1
Human neutralizing antibodies elicited by SARS-CoV-2 infection.SARS-CoV-2 感染诱导的人体中和抗体。
Nature. 2020 Aug;584(7819):115-119. doi: 10.1038/s41586-020-2380-z. Epub 2020 May 26.
2
Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China.从中国武汉的传播动态估计 COVID-19 的临床严重程度。
Nat Med. 2020 Apr;26(4):506-510. doi: 10.1038/s41591-020-0822-7. Epub 2020 Mar 19.
3
The proximal origin of SARS-CoV-2.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的近端起源。
英国泽西岛新冠肺炎住院患者的实验室特征
EJIFCC. 2022 Aug 8;33(2):105-120. eCollection 2022 Aug.
4
Developing dendritic cell for SARS-CoV-2 vaccine: Breakthrough in the pandemic.开发针对 SARS-CoV-2 的树突状细胞疫苗:大流行中的突破。
Front Immunol. 2022 Sep 6;13:989685. doi: 10.3389/fimmu.2022.989685. eCollection 2022.
5
Diagnostic power of one-step and two-step RT-qPCR methods to SARS‑CoV‑2 detection.一步法和两步法 RT-qPCR 方法检测 SARS-CoV-2 的诊断效能。
BMC Infect Dis. 2022 May 31;22(1):505. doi: 10.1186/s12879-022-07478-0.
6
SARS-CoV-2 infection causes intestinal cell damage: Role of interferon's imbalance.SARS-CoV-2 感染导致肠道细胞损伤:干扰素失衡的作用。
Cytokine. 2022 Apr;152:155826. doi: 10.1016/j.cyto.2022.155826. Epub 2022 Feb 10.
7
Multiplexed flow cytometric approach for detection of anti-SARS-CoV-2 IgG, IgM and IgA using beads covalently coupled to the nucleocapsid protein.基于与核衣壳蛋白共价偶联的珠子的多重流式细胞术检测抗 SARS-CoV-2 IgG、IgM 和 IgA 的方法。
Lett Appl Microbiol. 2022 Jun;74(6):863-872. doi: 10.1111/lam.13674. Epub 2022 Feb 19.
8
SARS-CoV-2 Neutralizing Antibody Levels Post COVID-19 Vaccination Based on ELISA Method-A Small Real-World Sample Exploration.基于ELISA法的新冠疫苗接种后SARS-CoV-2中和抗体水平——一项小型真实世界样本探索
Vaccines (Basel). 2021 Oct 6;9(10):1139. doi: 10.3390/vaccines9101139.
9
Protein PGLYRP1/Tag7 Peptides Decrease the Proinflammatory Response in Human Blood Cells and Mouse Model of Diffuse Alveolar Damage of Lung through Blockage of the TREM-1 and TNFR1 Receptors.蛋白 PGLYRP1/Tag7 肽通过阻断 TREM-1 和 TNFR1 受体减少人血细胞和弥漫性肺泡损伤小鼠模型的促炎反应。
Int J Mol Sci. 2021 Oct 18;22(20):11213. doi: 10.3390/ijms222011213.
10
ATR-FTIR spectrum analysis of saliva samples from COVID-19 positive patients.对 COVID-19 阳性患者的唾液样本进行 ATR-FTIR 光谱分析。
Sci Rep. 2021 Oct 7;11(1):19980. doi: 10.1038/s41598-021-99529-w.
Nat Med. 2020 Apr;26(4):450-452. doi: 10.1038/s41591-020-0820-9.
4
Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019.新型冠状病毒病 2019 患者的 SARS-CoV-2 抗体反应。
Clin Infect Dis. 2020 Nov 19;71(16):2027-2034. doi: 10.1093/cid/ciaa344.
5
Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2).连花清瘟对新型冠状病毒(SARS-CoV-2)具有抗病毒和抗炎作用。
Pharmacol Res. 2020 Jun;156:104761. doi: 10.1016/j.phrs.2020.104761. Epub 2020 Mar 20.
6
Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2).大量未记录的感染使新型冠状病毒(SARS-CoV-2)迅速传播。
Science. 2020 May 1;368(6490):489-493. doi: 10.1126/science.abb3221. Epub 2020 Mar 16.
7
[A pathological report of three COVID-19 cases by minimal invasive autopsies].[三例新冠病毒病病例微创尸检病理报告]
Zhonghua Bing Li Xue Za Zhi. 2020 May 8;49(5):411-417. doi: 10.3760/cma.j.cn112151-20200312-00193.
8
Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies.新型冠状病毒(COVI-19 或 SARS-CoV-2)诱导促炎细胞因子(IL-1 和 IL-6)和肺部炎症:抗炎策略。
J Biol Regul Homeost Agents. 2020;34(2):327-331. doi: 10.23812/CONTI-E.
9
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status.2019 冠状病毒病(COVID-19)疫情的起源、传播和临床治疗——现状更新。
Mil Med Res. 2020 Mar 13;7(1):11. doi: 10.1186/s40779-020-00240-0.
10
The convalescent sera option for containing COVID-19.使用康复期血清来控制新型冠状病毒肺炎。
J Clin Invest. 2020 Apr 1;130(4):1545-1548. doi: 10.1172/JCI138003.